411 related articles for article (PubMed ID: 25781910)
1. Hes1: a key role in stemness, metastasis and multidrug resistance.
Liu ZH; Dai XM; Du B
Cancer Biol Ther; 2015; 16(3):353-9. PubMed ID: 25781910
[TBL] [Abstract][Full Text] [Related]
2. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
[TBL] [Abstract][Full Text] [Related]
3. HES1 promoter activation dynamics reveal the plasticity, stemness and heterogeneity in neuroblastoma cancer stem cells.
Riya PA; Basu B; Surya S; Parvathy S; Lalitha S; Jyothi NP; Meera V; Jaikumar VS; Sunitha P; Shahina A; Sukumaran R; Nair AS; Dhanesh SB; Jiffy J; Nelson-Sati S; Maliekal TT; Das AV; James J
J Cell Sci; 2022 Nov; 135(22):. PubMed ID: 36321463
[TBL] [Abstract][Full Text] [Related]
4. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
5. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
6. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer.
Abel EV; Kim EJ; Wu J; Hynes M; Bednar F; Proctor E; Wang L; Dziubinski ML; Simeone DM
PLoS One; 2014; 9(3):e91983. PubMed ID: 24647545
[TBL] [Abstract][Full Text] [Related]
7. HES1 as an independent prognostic marker in esophageal squamous cell carcinoma.
Taleb S; Abbaszadegan MR; Moghbeli M; Roudbari NH; Forghanifard MM
J Gastrointest Cancer; 2014 Dec; 45(4):466-71. PubMed ID: 25139105
[TBL] [Abstract][Full Text] [Related]
8. Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression.
Kannan S; Fang W; Song G; Mullighan CG; Hammitt R; McMurray J; Zweidler-McKay PA
Blood; 2011 Mar; 117(10):2891-900. PubMed ID: 21224467
[TBL] [Abstract][Full Text] [Related]
9. Stochastic simulation of notch signaling reveals novel factors that mediate the differentiation of neural stem cells.
Tzou WS; Lo YT; Pai TW; Hu CH; Li CH
J Comput Biol; 2014 Jul; 21(7):548-67. PubMed ID: 24798230
[TBL] [Abstract][Full Text] [Related]
10. Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells.
Sang L; Roberts JM; Coller HA
Trends Mol Med; 2010 Jan; 16(1):17-26. PubMed ID: 20022559
[TBL] [Abstract][Full Text] [Related]
11. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding.
Yu X; Alder JK; Chun JH; Friedman AD; Heimfeld S; Cheng L; Civin CI
Stem Cells; 2006 Apr; 24(4):876-88. PubMed ID: 16513761
[TBL] [Abstract][Full Text] [Related]
12. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway.
Lee JH; Suk J; Park J; Kim SB; Kwak SS; Kim JW; Lee CH; Byun B; Ahn JK; Joe CO
Mol Cancer Res; 2009 Oct; 7(10):1663-71. PubMed ID: 19808903
[TBL] [Abstract][Full Text] [Related]
13. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
[TBL] [Abstract][Full Text] [Related]
14. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
15. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
[TBL] [Abstract][Full Text] [Related]
16. Hes1 promotes the IL-22-mediated antimicrobial response by enhancing STAT3-dependent transcription in human intestinal epithelial cells.
Murano T; Okamoto R; Ito G; Nakata T; Hibiya S; Shimizu H; Fujii S; Kano Y; Mizutani T; Yui S; Akiyama-Morio J; Nemoto Y; Tsuchiya K; Nakamura T; Watanabe M
Biochem Biophys Res Commun; 2014 Jan; 443(3):840-6. PubMed ID: 24342613
[TBL] [Abstract][Full Text] [Related]
17. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
[TBL] [Abstract][Full Text] [Related]
18. Expression dynamics and functions of Hes factors in development and diseases.
Kobayashi T; Kageyama R
Curr Top Dev Biol; 2014; 110():263-83. PubMed ID: 25248479
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
[TBL] [Abstract][Full Text] [Related]
20. Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling.
Ingram WJ; McCue KI; Tran TH; Hallahan AR; Wainwright BJ
Oncogene; 2008 Feb; 27(10):1489-500. PubMed ID: 17873912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
